CN110494129A - 一种乙酰氨基阿维菌素纳米乳及其制备方法和用途 - Google Patents
一种乙酰氨基阿维菌素纳米乳及其制备方法和用途 Download PDFInfo
- Publication number
- CN110494129A CN110494129A CN201780088184.3A CN201780088184A CN110494129A CN 110494129 A CN110494129 A CN 110494129A CN 201780088184 A CN201780088184 A CN 201780088184A CN 110494129 A CN110494129 A CN 110494129A
- Authority
- CN
- China
- Prior art keywords
- acetamido
- avermectin
- nanoemulsion
- weight
- emulsifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明提供了一种乙酰氨基阿维菌素纳米乳,该乙酰氨基阿维菌素纳米乳包含乙酰氨基阿维菌素,溶剂和长链一元酯,所述一元酯由式R‑COO‑R’表示,其中,R选自含有10‑16个碳原子的烷基,R’为含1‑5个碳原子的烷基,其中含1‑5个碳原子的烷基优选乙基、丙基、异丙基、丁基或异丁基。本发明还提供了一种制备乙酰氨基阿维菌素纳米乳的方法,其中,该方法包括如下步骤:(1)将乙酰氨基阿维菌素与溶剂混合均匀,得到第一混合物;(2)将所述第一混合物和长链一元酯以及乳化剂混合均匀,得到第二混合物;(3)将所述第二混合物与水混合均匀,得到第三混合物。本发明还提供了如上所述的方法制备得到的乙酰氨基阿维菌素纳米乳及其在杀灭动物体内寄生虫和体表寄生虫中的用途。
Description
PCT国内申请,说明书已公开。
Claims (28)
- PCT国内申请,权利要求书已公开。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2017/076074 WO2018161291A1 (zh) | 2017-03-09 | 2017-03-09 | 一种乙酰氨基阿维菌素纳米乳及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110494129A true CN110494129A (zh) | 2019-11-22 |
CN110494129B CN110494129B (zh) | 2022-12-30 |
Family
ID=63447292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780088184.3A Active CN110494129B (zh) | 2017-03-09 | 2017-03-09 | 一种乙酰氨基阿维菌素纳米乳及其制备方法和用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110494129B (zh) |
WO (1) | WO2018161291A1 (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006069580A1 (en) * | 2004-12-30 | 2006-07-06 | Cheminova A/S | Oil-in-water formulation of avermectins |
CN101309587A (zh) * | 2005-11-18 | 2008-11-19 | 凯米诺瓦有限公司 | 阿维菌素类的水包油制剂 |
CN101601394A (zh) * | 2009-07-14 | 2009-12-16 | 江苏龙灯化学有限公司 | 一种具有增效作用的杀虫剂组合物 |
CN102885060A (zh) * | 2012-09-29 | 2013-01-23 | 华南农业大学 | 一种阿维菌素纳米微乳剂及其制备方法 |
CN104706592A (zh) * | 2013-12-16 | 2015-06-17 | 天津迈迪瑞康生物医药科技有限公司 | 一种口服伊维菌素微乳浓缩液、其制备方法及用途 |
CN105769751A (zh) * | 2016-04-01 | 2016-07-20 | 江苏农牧科技职业学院 | 一种埃普利诺菌素乳剂凝胶及其制备方法 |
CN105851022A (zh) * | 2016-05-10 | 2016-08-17 | 中国科学院化学研究所 | 一种固态阿维菌素微粒制剂及其制备方法与应用 |
CN106243174A (zh) * | 2015-06-08 | 2016-12-21 | 龙灯农业化工国际有限公司 | 纯化甲氨基阿维菌素‑苯甲酸盐的方法以及含有所述甲氨基阿维菌素‑苯甲酸盐的组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2907012B1 (fr) * | 2006-10-12 | 2012-09-21 | Galderma Sa | Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation |
CN104095866B (zh) * | 2013-04-03 | 2017-02-22 | 华中农业大学 | 一种依普菌素透皮剂及制备方法及应用 |
CN106692054A (zh) * | 2016-10-20 | 2017-05-24 | 北京科百大科技有限责任公司 | 可耐酸催化降解的伊维菌素类药物液体制剂制备 |
-
2017
- 2017-03-09 WO PCT/CN2017/076074 patent/WO2018161291A1/zh active Application Filing
- 2017-03-09 CN CN201780088184.3A patent/CN110494129B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006069580A1 (en) * | 2004-12-30 | 2006-07-06 | Cheminova A/S | Oil-in-water formulation of avermectins |
CN101309587A (zh) * | 2005-11-18 | 2008-11-19 | 凯米诺瓦有限公司 | 阿维菌素类的水包油制剂 |
CN101601394A (zh) * | 2009-07-14 | 2009-12-16 | 江苏龙灯化学有限公司 | 一种具有增效作用的杀虫剂组合物 |
CN102885060A (zh) * | 2012-09-29 | 2013-01-23 | 华南农业大学 | 一种阿维菌素纳米微乳剂及其制备方法 |
CN104706592A (zh) * | 2013-12-16 | 2015-06-17 | 天津迈迪瑞康生物医药科技有限公司 | 一种口服伊维菌素微乳浓缩液、其制备方法及用途 |
CN106243174A (zh) * | 2015-06-08 | 2016-12-21 | 龙灯农业化工国际有限公司 | 纯化甲氨基阿维菌素‑苯甲酸盐的方法以及含有所述甲氨基阿维菌素‑苯甲酸盐的组合物 |
CN105769751A (zh) * | 2016-04-01 | 2016-07-20 | 江苏农牧科技职业学院 | 一种埃普利诺菌素乳剂凝胶及其制备方法 |
CN105851022A (zh) * | 2016-05-10 | 2016-08-17 | 中国科学院化学研究所 | 一种固态阿维菌素微粒制剂及其制备方法与应用 |
Non-Patent Citations (3)
Title |
---|
孟胜男等主编: "《药剂学》", 31 March 2016, 中国医药科技出版社 * |
张景云主编: "《实用美容药物学》", 31 July 2006, 中国中医药出版社 * |
贺尊诗等主编: "《有机药物质谱鉴定》", 28 February 1996, 吉林科学技术出版社 * |
Also Published As
Publication number | Publication date |
---|---|
WO2018161291A1 (zh) | 2018-09-13 |
CN110494129B (zh) | 2022-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lifschitz et al. | Moxidectin in cattle: correlation between plasma and target tissues disposition | |
Gokbulut et al. | Comparative plasma disposition, bioavailability and efficacy of ivermectin following oral and pour-on administrations in horses | |
JP2008540660A (ja) | 寄生虫の駆除用スポットオン製剤 | |
OA11678A (en) | Antiparasitic formulations. | |
EP1136081B1 (en) | Sustained-release compositions for the parenteral administration of macrolides | |
KR20100038118A (ko) | 체내구충 국소 조성물 | |
CN106132409B (zh) | 稳定的兽用驱虫制剂 | |
CA2364742C (en) | Anthelmintic composition | |
CA2594981C (en) | Anthelmintic composition | |
WO2015081401A1 (pt) | Processo para preparar uma composição anti-helmíntica, composição anti-helmíntica, método de tratamento veterinário e método de tratamento anti-helmíntico | |
KR870001791B1 (ko) | 비자극성 테트라미솔 또는 레바미솔 도포제 조성물 | |
CN111514157A (zh) | 组合物在制备兽用抗寄生虫病药物中的应用、兽用抗寄生虫病的透皮溶液及其制备方法 | |
US20170232026A1 (en) | Pharmaceutical composition in ivermectin emulgel for veterinary use as a promoter system and bio-adhesive in antiparasitic treatment, and method for the production thereof | |
CN108472286B (zh) | 一种用于杀灭动物体外寄生虫的药物组合物及其制备方法和用途 | |
Sallovitz et al. | A detailed assessment of the pattern of moxidectin tissue distribution after pour‐on treatment in calves | |
CN110494129B (zh) | 一种乙酰氨基阿维菌素纳米乳及其制备方法和用途 | |
CN107157995B (zh) | 一种宠物用广谱抗寄生虫的复方吡虫啉透皮组合物制剂 | |
Gokbulut et al. | Plasma disposition and milk excretion of eprinomectin following pour‐on administration in lactating donkeys | |
RU2634265C1 (ru) | Способ лечения демодекоза собак | |
Page et al. | Observations on topical ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats. | |
PT1646425E (pt) | Composição parasiticida | |
KR101233488B1 (ko) | 구충 제형 | |
RU2558074C1 (ru) | Способ лечения демодекоза крупного рогатого скота | |
RU2251421C2 (ru) | Противопаразитарный препарат для безыгольного введения | |
TWI751108B (zh) | 一種用於殺滅動物體外寄生蟲的藥物組合物及其製備方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |